| Year |
Citation |
Score |
| 2019 |
Sharma R, Cramer NP, Perry B, Adahman Z, Murphy EK, Xu X, Dardzinski BJ, Galdzicki Z, Perl DP, Dickstein DL, Iacono D. Chronic Exposure to High Altitude: Synaptic, Astroglial and Memory Changes. Scientific Reports. 9: 16406. PMID 31712561 DOI: 10.1038/S41598-019-52563-1 |
0.603 |
|
| 2018 |
Cramer NP, Korotcov A, Bosomtwi A, Xu X, Holman D, Whiting K, Jones S, Hoy A, Dardzinski BJ, Galdzicki Z. Neuronal and vascular deficits following chronic adaptation to high altitude. Experimental Neurology. PMID 30321497 DOI: 10.1016/J.Expneurol.2018.10.007 |
0.586 |
|
| 2018 |
Marion CM, Radomski KL, Cramer NP, Galdzicki Z, Armstrong RC. Experimental Traumatic Brain Injury Identifies Distinct Early and Late Phase Axonal Conduction Deficits of White Matter Pathophysiology, and Reveals Intervening Recovery. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30143572 DOI: 10.1523/JNEUROSCI.0819-18.2018 |
0.511 |
|
| 2016 |
Olmos-Serrano JL, Kang HJ, Tyler WA, Silbereis JC, Cheng F, Zhu Y, Pletikos M, Jankovic-Rapan L, Cramer NP, Galdzicki Z, Goodliffe J, Peters A, Sethares C, Delalle I, Golden JA, et al. Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination. Neuron. PMID 26924435 DOI: 10.1016/J.Neuron.2016.01.042 |
0.753 |
|
| 2015 |
Logue OC, Cramer NP, Xu X, Perl D, Galdzicki Z. Alterations of functional properties of hippocampal networks following repetitive closed-head injury. Experimental Neurology. PMID 26730521 DOI: 10.1016/J.Expneurol.2015.12.019 |
0.605 |
|
| 2015 |
Cramer NP, Xu X, F Haydar T, Galdzicki Z. Altered intrinsic and network properties of neocortical neurons in the Ts65Dn mouse model of Down syndrome. Physiological Reports. 3. PMID 26702072 DOI: 10.14814/Phy2.12655 |
0.631 |
|
| 2015 |
Cramer NP, Xu X, Christensen C, Bierman A, Tankersley CG, Galdzicki Z. Strain variation in the adaptation of C57Bl6 and BALBc mice to chronic hypobaric hypoxia. Physiology & Behavior. 143: 158-65. PMID 25647362 DOI: 10.1016/J.Physbeh.2015.01.036 |
0.527 |
|
| 2014 |
Rittase WB, Dong Y, Barksdale D, Galdzicki Z, Bausch SB. Dynorphin up-regulation in the dentate granule cell mossy fiber pathway following chronic inhibition of GluN2B-containing NMDAR is associated with increased CREB (Ser 133) phosphorylation, but is independent of BDNF/TrkB signaling pathways. Molecular and Cellular Neurosciences. 60: 63-71. PMID 24769103 DOI: 10.1016/j.mcn.2014.04.002 |
0.378 |
|
| 2012 |
Cramer N, Galdzicki Z. From abnormal hippocampal synaptic plasticity in down syndrome mouse models to cognitive disability in down syndrome. Neural Plasticity. 2012: 101542. PMID 22848844 DOI: 10.1155/2012/101542 |
0.651 |
|
| 2012 |
Best TK, Cramer NP, Chakrabarti L, Haydar TF, Galdzicki Z. Dysfunctional hippocampal inhibition in the Ts65Dn mouse model of Down syndrome. Experimental Neurology. 233: 749-57. PMID 22178330 DOI: 10.1016/J.Expneurol.2011.11.033 |
0.77 |
|
| 2012 |
Jaiswal MK, Lischka FW, Galdzicki Z. ISDN2012_0248: A fine balance between inhibition and excitation and the clusters of hyper/hypoactive neurons in sensory barrel cortex after traumatic brain injury International Journal of Developmental Neuroscience. 30: 686-687. DOI: 10.1016/j.ijdevneu.2012.10.049 |
0.315 |
|
| 2011 |
Keck-Wherley J, Grover D, Bhattacharyya S, Xu X, Holman D, Lombardini ED, Verma R, Biswas R, Galdzicki Z. Abnormal microRNA expression in Ts65Dn hippocampus and whole blood: contributions to Down syndrome phenotypes. Developmental Neuroscience. 33: 451-67. PMID 22042248 DOI: 10.1159/000330884 |
0.316 |
|
| 2011 |
Corbin JG, Paluszkiewicz SM, Martin BS, Huntsman MM, Tranfaglia MR, Liu C, Belichenko PV, Zhang L, Fu D, Kleschevnikov AM, Baldini A, Antonarakis SE, Mobley WC, Yu YE, Chakrabarti L, ... ... Galdzicki Z, et al. Author and Subject Index Developmental Neuroscience. 33: 468-468. DOI: 10.1159/000334885 |
0.579 |
|
| 2010 |
Cramer NP, Best TK, Stoffel M, Siarey RJ, Galdzicki Z. GABAB-GIRK2-mediated signaling in Down syndrome. Advances in Pharmacology (San Diego, Calif.). 58: 397-426. PMID 20655490 DOI: 10.1016/S1054-3589(10)58015-3 |
0.763 |
|
| 2010 |
Chakrabarti L, Best TK, Cramer NP, Carney RS, Isaac JT, Galdzicki Z, Haydar TF. Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome. Nature Neuroscience. 13: 927-34. PMID 20639873 DOI: 10.1038/Nn.2600 |
0.787 |
|
| 2009 |
Baek KH, Zaslavsky A, Lynch RC, Britt C, Okada Y, Siarey RJ, Lensch MW, Park IH, Yoon SS, Minami T, Korenberg JR, Folkman J, Daley GQ, Aird WC, Galdzicki Z, et al. Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature. 459: 1126-30. PMID 19458618 DOI: 10.1038/Nature08062 |
0.739 |
|
| 2008 |
Best TK, Cho-Clark M, Siarey RJ, Galdzicki Z. Speeding of miniature excitatory post-synaptic currents in Ts65Dn cultured hippocampal neurons. Neuroscience Letters. 438: 356-61. PMID 18490108 DOI: 10.1016/j.neulet.2008.04.039 |
0.791 |
|
| 2007 |
Chakrabarti L, Galdzicki Z, Haydar TF. Defects in embryonic neurogenesis and initial synapse formation in the forebrain of the Ts65Dn mouse model of Down syndrome. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 11483-95. PMID 17959791 DOI: 10.1523/Jneurosci.3406-07.2007 |
0.713 |
|
| 2007 |
Olson LE, Roper RJ, Sengstaken CL, Peterson EA, Aquino V, Galdzicki Z, Siarey R, Pletnikov M, Moran TH, Reeves RH. Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice. Human Molecular Genetics. 16: 774-82. PMID 17339268 DOI: 10.1093/Hmg/Ddm022 |
0.76 |
|
| 2007 |
Best TK, Siarey RJ, Galdzicki Z. Ts65Dn, a mouse model of Down syndrome, exhibits increased GABAB-induced potassium current. Journal of Neurophysiology. 97: 892-900. PMID 17093127 DOI: 10.1152/jn.00626.2006 |
0.789 |
|
| 2006 |
Siarey RJ, Kline-Burgess A, Cho M, Balbo A, Best TK, Harashima C, Klann E, Galdzicki Z. Altered signaling pathways underlying abnormal hippocampal synaptic plasticity in the Ts65Dn mouse model of Down syndrome. Journal of Neurochemistry. 98: 1266-77. PMID 16895585 DOI: 10.1111/J.1471-4159.2006.04238.X |
0.763 |
|
| 2006 |
Harashima C, Jacobowitz DM, Stoffel M, Chakrabarti L, Haydar TF, Siarey RJ, Galdzicki Z. Elevated expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in cerebellar unipolar brush cells of a Down syndrome mouse model. Cellular and Molecular Neurobiology. 26: 719-34. PMID 16783527 DOI: 10.1007/S10571-006-9066-4 |
0.801 |
|
| 2006 |
Harashima C, Jacobowitz DM, Witta J, Borke RC, Best TK, Siarey RJ, Galdzicki Z. Abnormal expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in hippocampus, frontal cortex, and substantia nigra of Ts65Dn mouse: a model of Down syndrome. The Journal of Comparative Neurology. 494: 815-33. PMID 16374808 DOI: 10.1002/Cne.20844 |
0.787 |
|
| 2005 |
Siarey RJ, Villar AJ, Epstein CJ, Galdzicki Z. Abnormal synaptic plasticity in the Ts1Cje segmental trisomy 16 mouse model of Down syndrome. Neuropharmacology. 49: 122-8. PMID 15992587 DOI: 10.1016/J.Neuropharm.2005.02.012 |
0.763 |
|
| 2003 |
Galdzicki Z, Siarey RJ. Understanding mental retardation in Down's syndrome using trisomy 16 mouse models. Genes, Brain, and Behavior. 2: 167-78. PMID 12931790 DOI: 10.1034/j.1601-183X.2003.00024.x |
0.772 |
|
| 2001 |
Klein RC, Warder SE, Galdzicki Z, Castellino FJ, Prorok M. Kinetic and mechanistic characterization of NMDA receptor antagonism by replacement and truncation variants of the conantokin peptides. Neuropharmacology. 41: 801-10. PMID 11684144 DOI: 10.1016/S0028-3908(01)00119-8 |
0.549 |
|
| 2001 |
Galdzicki Z, Siarey R, Pearce R, Stoll J, Rapoport SI. On the cause of mental retardation in Down syndrome: extrapolation from full and segmental trisomy 16 mouse models. Brain Research. Brain Research Reviews. 35: 115-45. PMID 11336779 DOI: 10.1016/S0926-6410(00)00074-4 |
0.779 |
|
| 2001 |
Klein RC, Prorok M, Galdzicki Z, Castellino FJ. The amino acid residue at sequence position 5 in the conantokin peptides partially governs subunit-selective antagonism of recombinant N-methyl-D-aspartate receptors. The Journal of Biological Chemistry. 276: 26860-7. PMID 11335724 DOI: 10.1074/Jbc.M102428200 |
0.522 |
|
| 2001 |
Klein RC, Siarey RJ, Caruso A, Rapoport SI, Castellino FJ, Galdzicki Z. Increased expression of NR2A subunit does not alter NMDA-evoked responses in cultured fetal trisomy 16 mouse hippocampal neurons. Journal of Neurochemistry. 76: 1663-9. PMID 11259484 DOI: 10.1046/J.1471-4159.2001.00170.X |
0.789 |
|
| 2000 |
Shetty HU, Siarey RJ, Galdzicki Z, Stoll J, Rapoport SI. Ts65Dn mouse, a Down syndrome model, exhibits elevated myo-inositol in selected brain regions and peripheral tissues. Neurochemical Research. 25: 431-5. PMID 10823574 DOI: 10.1023/A:1007592006005 |
0.725 |
|
| 1999 |
Siarey RJ, Carlson EJ, Epstein CJ, Balbo A, Rapoport SI, Galdzicki Z. Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome. Neuropharmacology. 38: 1917-20. PMID 10608287 DOI: 10.1016/S0028-3908(99)00083-0 |
0.745 |
|
| 1999 |
Klein RC, Galdzicki Z, Castellino FJ. Inhibition of NMDA-induced currents by conantokin-G and conantokin-T in cultured embryonic murine hippocampal neurons. Neuropharmacology. 38: 1819-29. PMID 10608277 DOI: 10.1016/S0028-3908(99)00065-9 |
0.53 |
|
| 1998 |
Galdzicki Z, Coan EJ, Rapoport SI, Stoll J. Increased expression of voltage-activated calcium channels in cultured hippocampal neurons from mouse trisomy 16, a model for Down syndrome. Brain Research. Molecular Brain Research. 56: 200-6. PMID 9602127 DOI: 10.1016/S0169-328X(98)00046-1 |
0.329 |
|
| 1998 |
Scortegagna M, Galdzicki Z, Rapoport SI, Hanbauer I. In cortical cultures of trisomy 16 mouse brain the upregulated metallothionein-I/II fails to respond to H2O2 exposure or glutamate receptor stimulation. Brain Research. 787: 292-8. PMID 9518655 DOI: 10.1016/S0006-8993(97)01501-1 |
0.329 |
|
| 1997 |
Siarey RJ, Stoll J, Rapoport SI, Galdzicki Z. Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down Syndrome. Neuropharmacology. 36: 1549-54. PMID 9517425 DOI: 10.1016/S0028-3908(97)00157-3 |
0.755 |
|
| 1997 |
Nelson PG, Fitzgerald S, Rapoport SI, Neale EA, Galdzicki Z, Dunlap V, Bowers L, v Agoston D. Cerebral cortical astroglia from the trisomy 16 mouse, a model for down syndrome, produce neuronal cholinergic deficits in cell culture. Proceedings of the National Academy of Sciences of the United States of America. 94: 12644-8. PMID 9356503 DOI: 10.1073/pnas.94.23.12644 |
0.332 |
|
| 1997 |
Siarey RJ, Coan EJ, Rapoport SI, Galdzicki Z. Responses to NMDA in cultured hippocampal neurons from trisomy 16 embryonic mice. Neuroscience Letters. 232: 131-4. PMID 9310297 DOI: 10.1016/S0304-3940(97)00581-8 |
0.751 |
|
| 1996 |
Stoll J, Galdzicki Z. Reduced expression of voltage-gated sodium channels in neurons cultured from trisomy 16 mouse hippocampus. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 14: 749-60. PMID 8960982 DOI: 10.1016/S0736-5748(96)00051-2 |
0.305 |
|
| 1995 |
Pearce R, Galdzicki Z, Rapoport SI. Decreased sensitivity to nerve growth factor of dorsal root ganglion neurons cultured from mouse trisomy 16, a model of Down's syndrome. Brain Research. 680: 108-16. PMID 7663966 DOI: 10.1016/0006-8993(95)00251-K |
0.312 |
|
| 1994 |
Rapoport SI, Galdzicki Z. Electrical studies of cultured fetal human trisomy 21 and mouse trisomy 16 neurons identify functional deficits that may lead to mental retardation in Down syndrome Developmental Brain Dysfunction. 7: 265-288. |
0.3 |
|
| 1993 |
Galdzicki Z, Coan E, Rapoport SI. Cultured hippocampal neurons from trisomy 16 mouse, a model for Down's syndrome, have an abnormal action potential due to a reduced inward sodium current. Brain Research. 604: 69-78. PMID 8384514 DOI: 10.1016/0006-8993(93)90353-O |
0.346 |
|
| Show low-probability matches. |